Trial Profile
Safety and efficacy of ripasudil in patients with glaucoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Sep 2016
Price :
$35
*
At a glance
- Drugs Ripasudil (Primary)
- Indications Glaucoma
- Focus Adverse reactions; Therapeutic Use
- 12 Sep 2016 New trial record
- 20 Jul 2016 Results published in the Advances in Therapy